Surprising Performance: $700 Million Vanished from U.S. Animal Health Stocks in a Day

Elanco Animal Health Incorporated (ELAN), a U.S. animal health company, reported strong first-quarter results on April 6 (local time), yet its shares plunged 6.8% to close at $24.40 in New York trading the following day. Its market capitalization fell by about $780 million in a single session—from roughly $12.1 billion to around $11.32 billion—wiping out nearly ₩1 trillion. Trading volume reached 7.23 million shares as selling pressure intensified immediately after the earnings release.

Elanco posted first-quarter revenues of $1.37 billion, a 15% increase year-over-year, and delivered earnings per share of $0.11, beating market expectations. The company reaffirmed its growth outlook by raising its full-year 2026 guidance, and pipeline momentum is highlighted by recent U.S. emergency use authorization for an insecticide product to control fly larvae infestations in feedlots. (investor.elanco.com)

Headquartered in Indianapolis, Indiana, Elanco is a global animal health company supplying vaccines, parasiticides and therapeutics for pets and livestock. It was spun off from Eli Lilly in 2018 and listed on the New York Stock Exchange. Beginning in 2026, Elanco has outlined a medium- to long-term strategy targeting mid-single-digit growth. (investor.elanco.com)